Defining the future of biomanufacturing




Mouseover boxes for more information

Recent News:

Xcellerex named to Inc. Magazine's list of fastest growing companies. more

Xcellerex introduces 10 Liter XDR-10 Single-Use Bioreactor more

Xcellerex Announces Sale of FlexFactory Bioproduction Line to R-Pharm for New Manufacturing Facility in Russia more

Xcellerex® and Gallus BioPharmaceuticals Announce Biomanufacturing Collaboration. more

First clinical trial results of Xcellerex inactivated vaccine against yellow fever published in New England Journal of Medicine. more

Xcellerex Welcomes ISPE Japan Dignitaries for Tour of New FlexFactory® Biomanufacturing Facility. more

Xcellerex recognized by Invensys with 2010 Productivity Excellence Award. more

GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program. more

Xcellerex Signs Memorandum of Understanding with SK Chemicals to Commercialize SK-Developed Vaccines with FlexFactory® Platform. more

Xcellerex Announces Appointment of Guy Broadbent as President and Chief Executive Officer. more

Xcellerex announces groundbreaking for new FlexFactory facility. more

Xcellerex and partners announce completion of successful test of Rapid Production of Swine Flu H1 Hemagglutinin. more

Introducing the 10 L XDR-10 Single-Use BioReactor. Xcellerex Ranks #1843 On INC. Magazine's List of Fastest Growing Private Companies